Ellington Management Group’s Cymabay Therapeutics CBAY Stock Holding History

Ellington Management Group’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,400	Closed	-$140K	–	733
2018 Q2	$140K	Buy	+10,400	New	+$130K	0.04%	442
2018 Q1	–	Sell	-20,600	Closed	-$190K	–	1069
2017 Q4	$190K	Sell	20,600 -8,700	-30%	-$74.3K	0.05%	497
2017 Q3	$236K	Buy	29,300 +12,200	+71%	+$82.5K	0.07%	473
2017 Q2	$98K	Buy	+17,100	New	+$72.8K	0.03%	598

Other funds holding CBAY

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return